Berberine exerts a protective effect against IRI-induced AKI by inhibiting the intestinal biological barrier of Proteobacteria, reducing lipopolysaccharide (LPS) production, and eliciting an anti-inflammatory response via the regulation of the Sirt1-NF-κB-TLR4 pathway [272]. This evidence concerns the gene NFKB1 and acute kidney injury.